In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Light from the outside world is focused onto a structure at the back of the eye called the retina. The central part of the retina - known as the macula - is crucial for vision. In some individuals the ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...